U.S. Markets closed

Boston Scientific’s latest deal is a good fit, analysts say

Ciara Linnane
Boston Scientific’s latest deal is a good fit, analysts say

Boston Scientific’s latest deal, a takeover of privately held Millipede, will help the company build out its franchise of heart-valve repair and replacement treatments, Needham analysts said Thursday.